{"podcast":{"title":"HCPLive Podcasts","slug":"hcplive-podcasts-19526","podcast_index_feed_id":19526,"rss_url":"https://audioboom.com/channels/5004077.rss","website_url":"https://audioboom.com/channels/5004077","image_url":"https://audioboom.com/i/40144427.png","author":"HCPLive.com","episode_count":243,"summary":"Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/hcplive-podcasts-19526"},"episode":{"title":"FSGS Drug Development No Longer a ‘Graveyard’: What Comes After Sparsentan’s Approval","slug":"fsgs-drug-development-no-longer-a-graveyard-what-comes-after-sparsentan-s-approval","published_at":"2026-04-19T18:09:43+00:00","page_url":"https://stenobird.com/podcast/hcplive-podcasts-19526/fsgs-drug-development-no-longer-a-graveyard-what-comes-after-sparsentan-s-approval","show_page_url":"https://stenobird.com/podcast/hcplive-podcasts-19526","url":"https://audioboom.com/posts/8891929","audio_url":"https://audioboom.com/posts/8891929.mp3?modified=1776622253&sid=5004077&source=rss","summary":null,"meta_description":null,"key_points":[],"chapters":[],"topics":[],"duration_seconds":827,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hcplive-podcasts-19526/episodes/fsgs-drug-development-no-longer-a-graveyard-what-comes-after-sparsentan-s-approval/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hcplive-podcasts-19526/fsgs-drug-development-no-longer-a-graveyard-what-comes-after-sparsentan-s-approval.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}